1. Home
  2. PHAT vs WTTR Comparison

PHAT vs WTTR Comparison

Compare PHAT & WTTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHAT
  • WTTR
  • Stock Information
  • Founded
  • PHAT 2018
  • WTTR 2016
  • Country
  • PHAT United States
  • WTTR United States
  • Employees
  • PHAT N/A
  • WTTR N/A
  • Industry
  • PHAT Biotechnology: Pharmaceutical Preparations
  • WTTR Oilfield Services/Equipment
  • Sector
  • PHAT Health Care
  • WTTR Energy
  • Exchange
  • PHAT Nasdaq
  • WTTR Nasdaq
  • Market Cap
  • PHAT 1.2B
  • WTTR 1.1B
  • IPO Year
  • PHAT 2019
  • WTTR 2017
  • Fundamental
  • Price
  • PHAT $8.78
  • WTTR $13.44
  • Analyst Decision
  • PHAT Strong Buy
  • WTTR Strong Buy
  • Analyst Count
  • PHAT 4
  • WTTR 2
  • Target Price
  • PHAT $22.50
  • WTTR $13.75
  • AVG Volume (30 Days)
  • PHAT 1.9M
  • WTTR 1.0M
  • Earning Date
  • PHAT 11-07-2024
  • WTTR 11-05-2024
  • Dividend Yield
  • PHAT N/A
  • WTTR 2.08%
  • EPS Growth
  • PHAT N/A
  • WTTR 11.32
  • EPS
  • PHAT N/A
  • WTTR 0.59
  • Revenue
  • PHAT $26,270,000.00
  • WTTR $1,477,888,000.00
  • Revenue This Year
  • PHAT $6,714.96
  • WTTR N/A
  • Revenue Next Year
  • PHAT $293.69
  • WTTR $6.39
  • P/E Ratio
  • PHAT N/A
  • WTTR $22.76
  • Revenue Growth
  • PHAT N/A
  • WTTR N/A
  • 52 Week Low
  • PHAT $6.07
  • WTTR $6.99
  • 52 Week High
  • PHAT $19.71
  • WTTR $14.48
  • Technical
  • Relative Strength Index (RSI)
  • PHAT 23.73
  • WTTR 64.26
  • Support Level
  • PHAT $8.91
  • WTTR $13.47
  • Resistance Level
  • PHAT $19.05
  • WTTR $14.05
  • Average True Range (ATR)
  • PHAT 1.74
  • WTTR 0.59
  • MACD
  • PHAT -1.05
  • WTTR 0.21
  • Stochastic Oscillator
  • PHAT 2.19
  • WTTR 75.09

About PHAT Phathom Pharmaceuticals Inc.

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

About WTTR Select Water Solutions Inc.

Select Water Solutions Inc provides sustainable water and chemical solutions to the energy industry. These solutions are supported by the company's critical water infrastructure assets, chemical manufacturing, and water treatment and recycling capabilities. Its reportable segments are Water Services, Water Infrastructure, and Chemical Technologies. It generates the majority of its revenue from Water Services.

Share on Social Networks: